0001127602-22-009217.txt : 20220314
0001127602-22-009217.hdr.sgml : 20220314
20220314215209
ACCESSION NUMBER: 0001127602-22-009217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220310
FILED AS OF DATE: 20220314
DATE AS OF CHANGE: 20220314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Day Daniel Patrick
CENTRAL INDEX KEY: 0001638643
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 22738676
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES, INC.
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: GILEAD SCIENCES INC
DATE OF NAME CHANGE: 19930328
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-03-10
0000882095
GILEAD SCIENCES, INC.
GILD
0001638643
O'Day Daniel Patrick
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
1
Chairman & CEO
Common Stock
2022-03-10
4
M
0
10800
0
A
247193
D
Common Stock
2022-03-10
4
M
0
13203
0
A
260396
D
Common Stock
2022-03-10
4
F
0
11052
57.92
D
249344
D
Restricted Stock Unit
2022-03-10
4
M
0
10800
D
Common Stock
10800
85772
D
Restricted Stock Unit
2022-03-10
4
M
0
13203
D
Common Stock
13203
72569
D
Non-qualified Stock Option (Right to Buy)
57.92
2022-03-10
4
A
0
399235
0
A
2032-03-10
Common Stock
399235
399235
D
Restricted Stock Unit
2022-03-10
4
A
0
64745
A
Common Stock
64745
137314
D
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
/s/ Amy Kim by Power of Attorney for Daniel O'Day
2022-03-14